company background image
524518 logo

Krebs Biochemicals & Industries BSE:524518 Stock Report

Last Price

₹70.82

Market Cap

₹1.5b

7D

-2.3%

1Y

-3.1%

Updated

24 Jun, 2024

Data

Company Financials

Krebs Biochemicals & Industries Limited

BSE:524518 Stock Report

Market Cap: ₹1.5b

524518 Stock Overview

Manufactures and sells active pharmaceutical ingredients in India.

524518 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Krebs Biochemicals & Industries Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Krebs Biochemicals & Industries
Historical stock prices
Current Share Price₹70.82
52 Week High₹93.20
52 Week Low₹60.00
Beta0.45
11 Month Change6.91%
3 Month Change6.54%
1 Year Change-3.12%
33 Year Change-39.75%
5 Year Change-13.05%
Change since IPO-74.08%

Recent News & Updates

Recent updates

Shareholder Returns

524518IN PharmaceuticalsIN Market
7D-2.3%-1.7%-0.1%
1Y-3.1%50.6%46.3%

Return vs Industry: 524518 underperformed the Indian Pharmaceuticals industry which returned 50.6% over the past year.

Return vs Market: 524518 underperformed the Indian Market which returned 46.3% over the past year.

Price Volatility

Is 524518's price volatile compared to industry and market?
524518 volatility
524518 Average Weekly Movement6.8%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement6.5%
10% most volatile stocks in IN Market9.5%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 524518 has not had significant price volatility in the past 3 months.

Volatility Over Time: 524518's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1991210Jitendra Shahkrebsbiochem.com

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications.

Krebs Biochemicals & Industries Limited Fundamentals Summary

How do Krebs Biochemicals & Industries's earnings and revenue compare to its market cap?
524518 fundamental statistics
Market cap₹1.53b
Earnings (TTM)-₹197.28m
Revenue (TTM)₹504.22m

3.0x

P/S Ratio

-7.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524518 income statement (TTM)
Revenue₹504.22m
Cost of Revenue₹65.87m
Gross Profit₹438.34m
Other Expenses₹635.63m
Earnings-₹197.28m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-9.15
Gross Margin86.94%
Net Profit Margin-39.13%
Debt/Equity Ratio-162.3%

How did 524518 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.